CPRX Stock Ownership Activity

CATALYST PHARMACEUTICALS INC 13F holders

2 value investing gurus have made changes to the CATALYST PHARMACEUTICALS INC (CPRX) position according to the gurus' latest SEC quarterly report(s). CPRX has been bought (as a new position) by 1 guru(s), the number of CPRX shares has been decreased by 1 super investor(s).

Which gurus or hedge funds are buying CPRX now?

According to the latest SEC filing(s) CATALYST PHARMACEUTICALS INC (CPRX) has been bought by Marty Whitman - Third Avenue Management (new buy).

To see more about who is investing in CATALYST PHARMACEUTICALS INC (CPRX), please go to the CPRX ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2026 Q1 (2 results)
Marty Whitman
Third Avenue Management
buy
+210,161
+0.84%
0.84%
Terry Smith
Fundsmith
-74.88%
-2,518,920
-0.49%
0.16%
Current price: $31.27 26.29% AVG reported price*: $24.76
2025 Q3 (1 result)
Terry Smith
Fundsmith
+24.17%
+654,721
+0.07%
0.33%
Current price: $31.27 58.73% Reported price*: $19.70
2025 Q2 (1 result)
Terry Smith
Fundsmith
+25.93%
+557,812
+0.05%
0.26%
Current price: $31.27 44.10% Reported price*: $21.70
2025 Q1 (1 result)
Terry Smith
Fundsmith
buy
+2,151,274
+0.24%
0.24%
Current price: $31.27 28.95% Reported price*: $24.25
5 of 5

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.